{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2026-07-30", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "safetyreportversion": "1", "safetyreportid": "19542960", "primarysourcecountry": "US", "occurcountry": "US", "transmissiondateformat": "102", "transmissiondate": "20211014", "reporttype": "1", "serious": "2", "receivedateformat": "102", "receivedate": "20210713", "receiptdateformat": "102", "receiptdate": "20210713", "fulfillexpeditecriteria": "2", "companynumb": "US-PFIZER INC-2021423831", "duplicate": "1", "reportduplicate": { "duplicatesource": "PFIZER", "duplicatenumb": "US-PFIZER INC-2021423831" }, "primarysource": { "reportercountry": "US", "qualification": "5" }, "sender": { "sendertype": "2", "senderorganization": "FDA-Public Use" }, "receiver": { "receivertype": "6", "receiverorganization": "FDA" }, "patient": { "patientonsetage": "53", "patientonsetageunit": "801", "patientweight": "49.89", "patientsex": "2", "reaction": [ { "reactionmeddraversionpt": "24.0", "reactionmeddrapt": "White blood cell count decreased", "reactionoutcome": "1" } ], "drug": [ { "drugcharacterization": "2", "medicinalproduct": "CALCIUM", "drugstructuredosagenumb": "500", "drugstructuredosageunit": "003", "drugdosagetext": "500 MG (500(1250) )", "drugdosageform": "TABLET", "activesubstance": { "activesubstancename": "CALCIUM" }, "openfda": { "brand_name": [ "7030 CALCIUM PREMIUM", "AG-X", "7030 CALCIUM GOLD" ], "generic_name": [ "CALCIUM" ], "manufacturer_name": [ "Apexel Co., Ltd", "APEXEL CO., LTD." ], "product_ndc": [ "55259-1112", "55259-0007", "55259-0001" ], "product_type": [ "HUMAN OTC DRUG" ], "route": [ "ORAL" ], "substance_name": [ "CALCIUM" ], "spl_id": [ "0fa8135f-89c9-41a2-e063-6294a90a403d", "11cc283a-fe2c-f101-e063-6294a90ad2d4", "11cc310a-d82e-be44-e063-6394a90a227c" ], "spl_set_id": [ "bdc7c833-daf7-48f9-e053-2995a90ad88e", "bdee5e24-645b-7fa0-e053-2995a90a7d25", "bdc7c088-83e3-20ce-e053-2995a90abd2f" ], "package_ndc": [ "55259-1112-1", "55259-0007-1", "55259-0001-1" ], "nui": [ "M0003153", "N0000175901" ], "pharm_class_cs": [ "Calcium [CS]" ], "pharm_class_epc": [ "Calcium [EPC]" ], "unii": [ "SY7Q814VUP" ] } }, { "drugcharacterization": "2", "medicinalproduct": "ATIVAN", "drugstructuredosagenumb": "1", "drugstructuredosageunit": "003", "drugdosagetext": "1 MG", "drugdosageform": "TABLET", "activesubstance": { "activesubstancename": "LORAZEPAM" }, "openfda": { "application_number": [ "NDA017794", "NDA018140" ], "brand_name": [ "ATIVAN" ], "generic_name": [ "LORAZEPAM" ], "manufacturer_name": [ "Bausch Health US LLC", "Hikma Pharmaceuticals USA Inc." ], "product_ndc": [ "0187-0063", "0187-0064", "0187-0065", "0641-6000", "0641-6003", "0641-6002", "0641-6001" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL", "INTRAMUSCULAR", "INTRAVENOUS" ], "substance_name": [ "LORAZEPAM" ], "rxcui": [ "104719", "197900", "197901", "197902", "206821", "206828", "206819", "206820", "238100", "238101", "1665188", "1665190", "1665326", "1665327" ], "spl_id": [ "93bdf2de-1222-44a4-b4d5-2280f9ce58d8", "209b0091-c890-4f69-a693-d0594c2606fe" ], "spl_set_id": [ "89057c93-8155-4040-acec-64e877bd2b4c", "5fc0e987-61c9-40c4-b0d5-fcea07c8733e" ], "package_ndc": [ "0187-0063-01", "0187-0063-50", "0187-0063-10", "0187-0064-01", "0187-0064-50", "0187-0064-10", "0187-0065-01", "0187-0065-50", "0187-0065-10", "0641-6003-01", "0641-6003-25", "0641-6002-01", "0641-6002-10", "0641-6001-01", "0641-6001-25", "0641-6000-01", "0641-6000-10" ], "nui": [ "N0000175694", "M0002356" ], "pharm_class_epc": [ "Benzodiazepine [EPC]" ], "pharm_class_cs": [ "Benzodiazepines [CS]" ], "unii": [ "O26FZP769L" ] } }, { "drugcharacterization": "2", "medicinalproduct": "COMPAZINE", "drugstructuredosagenumb": "10", "drugstructuredosageunit": "003", "drugdosagetext": "10 MG", "drugdosageform": "TABLET", "activesubstance": { "activesubstancename": "PROCHLORPERAZINE MALEATE" } }, { "drugcharacterization": "1", "medicinalproduct": "IBRANCE", "drugauthorizationnumb": "212436", "drugstructuredosagenumb": "125", "drugstructuredosageunit": "003", "drugdosagetext": "125 MG, CYCLIC (DAILY 21 DAYS)", "drugdosageform": "FILM-COATED TABLET", "drugadministrationroute": "048", "drugstartdateformat": "610", "drugstartdate": "202102", "actiondrug": "5", "drugadditional": "3", "activesubstance": { "activesubstancename": "PALBOCICLIB" }, "openfda": { "application_number": [ "NDA207103", "NDA212436" ], "brand_name": [ "IBRANCE" ], "generic_name": [ "PALBOCICLIB" ], "manufacturer_name": [ "Pfizer Laboratories Div Pfizer Inc", "U.S. Pharmaceuticals" ], "product_ndc": [ "0069-0187", "0069-0188", "0069-0189", "63539-284", "63539-486", "63539-688", "0069-0284", "0069-0486", "0069-0688" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "PALBOCICLIB" ], "rxcui": [ "1601380", "1601386", "1601388", "1601390", "1601392", "1601394", "2284102", "2284104", "2284105", "2284106", "2284107", "2284108" ], "spl_id": [ "7dcc9b87-0aa4-4a00-aced-96be3553e8ac", "342c459f-fe40-4422-bc31-88d16fbbd4df", "0bf98e9e-7794-47ec-a88f-2fb726c7861a" ], "spl_set_id": [ "e0e6412f-50b4-4fd4-9364-62818d121a07", "89a142d5-7e61-48bf-9e77-e2cd124c4792", "fecbdd7d-b729-41b5-9872-231b8fe104ce" ], "package_ndc": [ "0069-0187-21", "0069-0188-21", "0069-0189-21", "63539-284-07", "63539-284-03", "63539-486-07", "63539-486-03", "63539-688-07", "63539-688-03", "0069-0284-07", "0069-0284-03", "0069-0486-07", "0069-0486-03", "0069-0688-07", "0069-0688-03" ], "nui": [ "N0000175605", "N0000175082", "N0000190114" ], "pharm_class_epc": [ "Kinase Inhibitor [EPC]" ], "pharm_class_moa": [ "Kinase Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]" ], "unii": [ "G9ZF61LE7G" ] } }, { "drugcharacterization": "2", "medicinalproduct": "LETROZOLE.", "drugstructuredosagenumb": "2.5", "drugstructuredosageunit": "003", "drugdosagetext": "2.5 MG", "drugdosageform": "TABLET", "activesubstance": { "activesubstancename": "LETROZOLE" }, "openfda": { "application_number": [ "ANDA090934", "ANDA091191", "ANDA211717", "ANDA200161", "ANDA090289", "ANDA205869", "NDA020726" ], "brand_name": [ "LETROZOLE", "FEMARA" ], "generic_name": [ "LETROZOLE", "LETROZOLE TABLETS" ], "manufacturer_name": [ "Accord Healthcare, Inc.", "Dr. Reddy's Laboratories Limited", "Aurobindo Pharma Limited", "Natco Pharma Limited", "Teva Pharmaceuticals USA, Inc.", "Chartwell RX, LLC", "Breckenridge Pharmaceutical, Inc.", "Novartis Pharmaceuticals Corporation", "Avet Pharmaceuticals Inc.", "Yiling Pharmaceutical, Inc.", "Upsher-Smith Laboratories, LLC", "Carnegie Pharmaceuticals LLC" ], "product_ndc": [ "16729-034", "55111-646", "59651-180", "63850-0025", "0093-7620", "62135-491", "51991-759", "0078-0249", "23155-875", "69117-0004", "24979-726", "80005-139" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "LETROZOLE" ], "rxcui": [ "200064", "153124" ], "spl_id": [ "4a681bf4-9779-a1b2-e063-6294a90a83db", "ec1b249b-2d77-55d9-0520-23884a961cf0", "2cd5dbfd-2432-4cea-bee2-6b710b5d28a2", "7917d6e0-df93-4c10-97c9-3d90b00b7bd4", "c91fb703-e253-490e-bb1d-48d054d81c6e", "456ed484-059b-2ee9-e063-6294a90a3f83", "1bd709a7-993a-4e55-9bb5-d5f42678e7b9", "28456311-e797-457f-8a9e-54dca5a7a336", "40009527-770b-8999-e063-6294a90a9946", "4721d1b1-3a04-27fb-e063-6394a90a7c1a", "4d5cb59c-11c3-4b0d-e063-6294a90a5b87", "9fb66539-2efe-47cc-9b78-85b096caac95" ], "spl_set_id": [ "c391fe11-fd47-4a35-af6d-c823ab7b8838", "6cfd29d7-f519-7b8c-4814-07b39f367f0d", "ff7325d2-3383-4ff9-a187-9350e3538640", "35c73219-c39e-4e10-b944-76009b061e79", "8ebda73d-82a3-4b17-8a81-a1f258003d32", "fa2d40a5-3504-44ef-8f5c-aa4c06308074", "63e54b62-a30d-4a56-9215-75e7a0b0bf02", "82b77d74-085f-45ac-a7dd-1f5c038bf406", "fe0e4d4b-436d-a36d-e053-6294a90a973d", "7b00e08c-9a1c-09e0-e053-2a91aa0a7638", "2d1f18f0-2c77-407c-b702-2d1b07f92510", "cb1da0ac-8db1-4482-824d-430511d1b7a0" ], "package_ndc": [ "16729-034-10", "16729-034-15", "16729-034-01", "16729-034-16", "16729-034-17", "16729-034-43", "55111-646-30", "55111-646-79", "55111-646-78", "59651-180-30", "59651-180-90", "63850-0025-1", "63850-0025-4", "0093-7620-56", "62135-491-30", "62135-491-90", "51991-759-33", "51991-759-10", "51991-759-90", "0078-0249-15", "23155-875-03", "23155-875-09", "23155-875-10", "69117-0004-1", "24979-726-07", "80005-139-08", "80005-139-10" ], "nui": [ "N0000175563", "N0000175080" ], "pharm_class_epc": [ "Aromatase Inhibitor [EPC]" ], "pharm_class_moa": [ "Aromatase Inhibitors [MoA]" ], "unii": [ "7LKK855W8I" ] } }, { "drugcharacterization": "2", "medicinalproduct": "MARINOL", "drugstructuredosagenumb": "200", "drugstructuredosageunit": "003", "drugdosagetext": "200 MG (1B 200 MG)", "drugdosageform": "CAPSULE", "activesubstance": { "activesubstancename": "DRONABINOL" }, "openfda": { "application_number": [ "NDA018651" ], "brand_name": [ "MARINOL" ], "generic_name": [ "DRONABINOL" ], "manufacturer_name": [ "ThePharmaNetwork, LLC" ], "product_ndc": [ "53097-568", "53097-569", "53097-570", "53097-571", "53097-572", "53097-573" ], "product_type": [ "HUMAN PRESCRIPTION DRUG" ], "route": [ "ORAL" ], "substance_name": [ "DRONABINOL" ], "rxcui": [ "197634", "197635", "197636", "205641", "205642", "205645" ], "spl_id": [ "628f9609-6583-49be-be77-b64cfbc46fd7", "5ce802d5-e8ab-4cd1-9ba0-1f39f22ddd48" ], "spl_set_id": [ "628f9609-6583-49be-be77-b64cfbc46fd7", "d0efeeec-640d-43c3-8f0a-d31324a11c68" ], "package_ndc": [ "53097-568-60", "53097-569-60", "53097-570-60", "53097-571-60", "53097-572-60", "53097-573-60" ], "nui": [ "N0000175782", "M0003267" ], "pharm_class_epc": [ "Cannabinoid [EPC]" ], "pharm_class_cs": [ "Cannabinoids [CS]" ], "unii": [ "7J8897W37S" ] } } ] } } ] }